Last Updated 24 February 2021.
This vaccine is approved.
Approved in 63 countries
9 trials in 9 countries
This vaccine has reached Phase 3 trials.
5 trials in 3 countries
© 2021 McGill COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form